Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 343

recruiting
3 975
countries
28
conditions
2 109

10 403 trials match your criteria

Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years

Safety and Efficacy of MK-1045 with Tocilizumab in Patients with CLL/SLL

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Histamine Dihydrochloride

Study of oral STL303 hydrochloride to assess safety and effectiveness in adults with geographic atrophy secondary to age‑related macular degeneration

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Adrenoleukodystrophy

Not yet recruiting

Safety and Early Benefit of Allogeneic Bone Marrow‑Derived Mesenchymal Stromal Cells in Children and Adolescents with X‑Linked Adrenoleukodystrophy

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years

Study of elranatamab, mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Safety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Type 2 diabetes mellitus

Not yet recruiting

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Albiglutide

Hypertrophic cardiomyopathy

Not yet recruiting

Effect of oral mavacamten on left ventricular filling pressure in patients with hypertrophic cardiomyopathy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.